When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 2016
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Administration, Oral (MeSH)
- Antibodies, Monoclonal, Humanized (MeSH)
- Anticoagulants (MeSH)
- Antidotes (MeSH)
- Arginine (MeSH)
- Blood Coagulation (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Coagulants (MeSH)
- Factor Xa (MeSH)
- Hemorrhage (MeSH)
- Humans (MeSH)
- Piperazines (MeSH)
- Recombinant Proteins (MeSH)